Historical Stock Price
ETFs Holding ACOR »    ACOR Split History »
Video: Compound Annual Growth Rate (CAGR) Definition


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Date Open High Low Close Volume
12/02/2022 $0.60 $0.64 $0.60 $0.61 139.70K
12/05/2022 $0.60 $0.63 $0.59 $0.59 155.00K
12/06/2022 $0.57 $0.59 $0.51 $0.57 177.70K
12/07/2022 $0.58 $0.59 $0.46 $0.53 305.50K
12/08/2022 $0.53 $0.60 $0.51 $0.56 57.90K
Acorda Therapeutics is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Co. markets Inbrija (levodopa inhalation powder), which is approved for intermittent treatment of episodic motor fluctuations, also known as OFF periods, in people with Parkinson's disease treated with carbidopa/levodopa. Inbrija utilizes Co.'s ARCUS pulmonary delivery system, a technology platform designed to deliver medication through inhalation. Co. also markets Ampyra (dalfampridine) extended release tablets, 10 mg for improving walking in patients with multiple sclerosis. Ampyra is marketed as Fampyra outside the U.S.
ACOR historical stock prices picture
Acorda Therapeutics (ACOR) has the following price history information. Looking back at ACOR historical stock prices for the last five trading days, on December 02, 2022, ACOR opened at $0.60, traded as high as $0.64 and as low as $0.60, and closed at $0.61. Trading volume was a total of 139.70K shares. On December 05, 2022, ACOR opened at $0.60, traded as high as $0.63 and as low as $0.59, and closed at $0.59. Trading volume was a total of 155.00K shares. On December 06, 2022, ACOR opened at $0.57, traded as high as $0.59 and as low as $0.51, and closed at $0.57. Trading volume was a total of 177.70K shares. On December 07, 2022, ACOR opened at $0.58, traded as high as $0.59 and as low as $0.46, and closed at $0.53. Trading volume was a total of 305.50K shares. On December 08, 2022, ACOR opened at $0.53, traded as high as $0.60 and as low as $0.51, and closed at $0.56. Trading volume was a total of 57.90K shares.

ACOR Historical Stock Prices By Date:

ACOR historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acorda Therapeutics shares, starting with a $10,000 purchase of ACOR, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 12/11/2012
End date: 12/08/2022
Start price/share: $154.50
End price/share: $0.56
Dividends collected/share: $0.00
Total return: -99.64%
Average Annual Total Return: -43.00%
Starting investment: $10,000.00
Ending investment: $36.26
Years: 10.00
Date Close
12/02/2022$0.61
12/05/2022$0.59
12/06/2022$0.57
12/07/2022$0.53
12/08/2022$0.56
ACOR is categorized under the Healthcare sector; below are some other companies in the same sector:

ACRS Historical Stock Prices
ACRX Historical Stock Prices
ACST Historical Stock Prices
ACT Historical Stock Prices
ACUR Historical Stock Prices
ADHD Historical Stock Prices
ADK Historical Stock Prices
ADMA Historical Stock Prices
ADMP Historical Stock Prices
ADMS Historical Stock Prices

Also explore: ACOR shares outstanding history

Email EnvelopeFree ACOR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

ACOR Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.